Customer Center
Login | Register

xMAP® Assays Reveal More About Immune Response than Traditional Vaccine ELISAs

May 30th, 2018 / Hilary Graham

Serotype-specific assays pinpoint threshold values missed by standard tests If you use ELISAs to test immunological responses, Siân Faustini from the University of Birmingham has this advice: “Serotype-specific assays are the way to go.” In her 20-minute webinar presentation from xMAP® Connect 2017, “Exploring immunological assays to assess responses to pneumococcal polysaccharide and conjugate vaccines

Continue reading »

Drop the Blot: Parallel Quantification of Up to 800 Proteins

May 22nd, 2018 / Hilary Graham

Powered by Luminex beads, DigiWest reinvents the Western blot About a year and a half ago, we introduced blog readers to a cool new alternative to the laborious Western blot: DigiWest®, a highly paralleled protein expression technology developed by scientists at the University of Tübingen. The approach combines xMAP® bead-based multiplexing technology with the concept

Continue reading »

The Faces of Luminex: Joern Mosner, Assay R&D

May 18th, 2018 / Christine Valle

When you think about research and development at a company like Luminex, your mind probably goes straight to the instruments we produce — the sophisticated technology platforms like our ARIES® System. However, those systems wouldn’t be nearly as valuable to customers without having top-notch assays to run on them, and that’s where Joern Mosner, Vice

Continue reading »

Luminex Licensed Technologies Partner Spotlight: Hakken Enterprise

May 17th, 2018 / Hilary Graham

Innovative genetic tests for everyday life Luminex Licensed Technologies Partners span a broad range of markets, company sizes and stages, and locations. The versatility of xMAP® Technology has supported the launch of thousands of multiplexed nucleic acid detection assays and immunoassays formatted into commercially available kits and testing services. Gisela Aguirre, PhD, is CEO of

Continue reading »

The Faces of Luminex: Ben Treece, Quality Assurance

May 4th, 2018 / Christine Valle

If a Luminex reagent, assay, or instrument is manufactured in our Austin headquarters, its quality compliance has been checked by Ben Treece, Senior Manager of Quality Assurance, and his team. He earned his bachelor’s degree in chemistry from the University of Texas at Austin and joined Luminex in 2006. Q: What are your responsibilities at

Continue reading »

Webinar Wednesday: Reduce False Positive Results in HLA Testing with Immucor Assay

May 2nd, 2018 / Hilary Graham

xMAP® bead-based multiplexing technology helps eliminate denatured antigens Scientists who perform HLA antibody tests are all too familiar with the challenge of false positives: many assays react with denatured antigens to generate a positive result even when the intact antigen was not detected. Various approaches have been used to overcome this, but a new method

Continue reading »

Welcome to Austin, Immunology Attendees!

April 27th, 2018 / Christine Valle

For immunoassays, xMAP® Technology offers major advantages We can’t wait for the leading annual all-immunology event to land in our back yard! This week, the annual meeting of the American Association of Immunologists kicks off in our hometown of Austin, TX, running from May 4-8 at the city’s convention center. The conference, known within the

Continue reading »

Treat Me Right: CDC’s Message for STD Awareness Month

April 26th, 2018 / Christine Valle

Diagnostic developers have an important role in fighting the spread of STDs April is STD Awareness Month — a particularly important milestone in recent years as STD transmissions are higher than ever, according to the U.S. Centers for Disease Control and Prevention (CDC). This year, CDC has a new theme for STD Awareness Month: “Treat

Continue reading »

Webinar Wednesday: Overcome Biomarker Multiplexing Challenges in Drug Development

April 18th, 2018 / Hilary Graham

Paul Rhyne from BDS Shares Recommended Multiplexing Techniques Paul Rhyne, PhD, Chief Scientific Officer at Biologic Development Services (BDS), shares insights from a review article co-authored with 11 colleagues from pharmaceutical companies, clinical research organizations (CRO), and government agencies over two years titled: Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in

Continue reading »

The Faces of Luminex: Alan Virden, Hardware Product Services

April 13th, 2018 / Christine Valle

Preparing documentation and training for Luminex products was a lot easier back when we only sold one instrument. Alan Virden, Hardware Product Services Manager, knows that from personal experience. He joined Luminex in 1998 even before the company launched its first commercial product. Today, he plays an integral role for all of our products —

Continue reading »